Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 6.725.865.464.847.72

What is the latest EV/Core EBITDA ratio of BLISS GVS PHARMA ?

The latest EV/Core EBITDA ratio of BLISS GVS PHARMA is 6.72 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20256.72
Mar20245.86
Mar20235.46
Mar20224.84
Mar20217.72

How is EV/Core EBITDA of BLISS GVS PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 6.72
14.68
Mar2024 5.86
7.33
Mar2023 5.46
12.81
Mar2022 4.84
-37.31
Mar2021 7.72 -

Other Financial Ratios of BLISS GVS PHARMA


Compare EV/Core EBITDA ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,762.0 Cr 0.3% 8.4% -7.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,343.0 Cr -0.7% 7.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹171,774.0 Cr -0.1% -4.8% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,665.0 Cr 2.2% 6.3% 11.4% Stock Analytics
CIPLA ₹122,878.0 Cr -0.6% 1.2% NA Stock Analytics
DR REDDYS LABORATORIES ₹106,581.0 Cr 1.5% 6.4% 4.8% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

0.3%

8.4%

-7.9%

SENSEX

-0.5%

1.5%

6.9%


You may also like the below Video Courses